Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 15, 2019 - Issue
Submit an article Journal homepage
103
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Use of the Functioning Assessment Short Test (FAST) in defining functional recovery in bipolar I disorder. Post-hoc analyses of long-term studies of aripiprazole once monthly as maintenance treatment

Jessica Madera1 Medical Affairs, Otsuka Pharmaceutical Development and Commercialization Inc, Princeton, NJ, USA
,
Pedro Such2 Medical Affairs, H. Lundbeck A/S, Valby, Denmark
,
Peter Zhang1 Medical Affairs, Otsuka Pharmaceutical Development and Commercialization Inc, Princeton, NJ, USA
,
Ross A Baker1 Medical Affairs, Otsuka Pharmaceutical Development and Commercialization Inc, Princeton, NJ, USA
&
Iria Grande3 Bipolar and Depression Disorders Unit, Hospital Clinic, Institute of Neurosciences, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, SpainCorrespondence[email protected]
Pages 2325-2338 | Published online: 15 Aug 2019

References

  • Sanchez-Moreno J, Martinez-Aran A, Tabares-Seisdedos R, Torrent C, Vieta E, Ayuso-Mateos JL. Functioning and disability in bipolar disorder: an extensive review. Psychother Psychosom. 2009;78(5):285–297. doi:10.1159/00022824919602917
  • Chou YH, Chu PC, Wu SW, et al. A systemic review and experts’ consensus for long-acting injectable antipsychotics in bipolar disorder. Clin Psychopharmacol Neurosci. 2015;13(2):121–128. doi:10.9758/cpn.2015.13.2.12126243837
  • Derry S, Moore RA. Atypical antipsychotics in bipolar disorder: systematic review of randomised trials. BMC Psychiatry. 2007;7:40. doi:10.1186/1471-244X-7-4017705840
  • Vieta E, Berk M, Schulze TG, et al. Bipolar disorders. Nat Rev Dis Primers. 2018;4:18008. doi:10.1038/nrdp.2018.829516993
  • Lahteenvuo M, Tanskanen A, Taipale H, et al. Real-world effectiveness of pharmacologic treatments for the prevention of rehospitalization in a finnish nationwide cohort of patients with bipolar disorder. JAMA Psychiatry. 2018;75(4):347–355. doi:10.1001/jamapsychiatry.2017.471129490359
  • Torres-Llenza V, Lakshmin P, Lieberman DZ. Spotlight on once-monthly long-acting injectable aripiprazole and its potential as maintenance treatment for bipolar I disorder in adult patients. Neuropsychiatr Dis Treat. 2018;14:285–292. doi:10.2147/NDT.S12955929391801
  • Calabrese JR, Sanchez R, Jin N, et al. Efficacy and safety of aripiprazole once-monthly in the maintenance treatment of bipolar I disorder: a double-blind, placebo-controlled, 52-week randomized withdrawal study. J Clin Psychiatry. 2017;78(3):324–331. doi:10.4088/JCP.16m1120128146613
  • Calabrese JR, Jin N, Johnson B, et al. Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study. Int J Bipolar Disord. 2018;6(1):14. doi:10.1186/s40345-018-0122-z29886522
  • Harvey PD. Defining and achieving recovery from bipolar disorder. J Clin Psychiatry. 2006;67(Suppl 9):14–18; discussion 36–42.
  • Rosa AR, Sanchez-Moreno J, Martinez-Aran A, et al. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health. 2007;3:5. doi:10.1186/1745-0179-3-517555558
  • Calabrese JR, Sanchez R, Jin N, et al. Symptoms and functioning with aripiprazole once-monthly injection as maintenance treatment for bipolar I disorder. J Affect Disord. 2018;227:649–656.29174738
  • Tohen M, Frank E, Bowden CL, et al. The International Society for Bipolar Disorders (ISBD) task force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord. 2009;11(5):453–473. doi:10.1111/j.1399-5618.2009.00726.x19624385
  • Bonnin CM, Martinez-Aran A, Reinares M, et al. Thresholds for severity, remission and recovery using the functioning assessment short test (FAST) in bipolar disorder. J Affect Disord. 2018;240:57–62. doi:10.1016/j.jad.2018.07.04530053684
  • Gitlin MJ, Miklowitz DJ. The difficult lives of individuals with bipolar disorder: a review of functional outcomes and their implications for treatment. J Affect Disord. 2017;209:147–154. doi:10.1016/j.jad.2016.11.02127914248
  • Rosa AR, Bonnin CM, Vazquez GH, et al. Functional impairment in bipolar II disorder: is it as disabling as bipolar I? J Affect Disord. 2010;127(1–3):71–76. doi:10.1016/j.jad.2010.05.01420538343
  • Chengappa KN, Hennen J, Baldessarini RJ, et al. Recovery and functional outcomes following olanzapine treatment for bipolar I mania. Bipolar Disord. 2005;7(1):68–76. doi:10.1111/j.1399-5618.2004.00171.x15654934
  • Sole B, Bonnin CM, Jimenez E, et al. Heterogeneity of functional outcomes in patients with bipolar disorder: a cluster-analytic approach. Acta Psychiatr Scand. 2018;137(6):516–527. doi:10.1111/acps.1287129508379
  • Dodd AL, Mezes B, Lobban F, Jones SH. Psychological mechanisms and the ups and downs of personal recovery in bipolar disorder. Br J Clin Psychol. 2017;56(3):310–328. doi:10.1111/bjc.1214028543095
  • Grande I, Goikolea JM, de Dios C, et al. Occupational disability in bipolar disorder: analysis of predictors of being on severe disablement benefit (PREBIS study data). Acta Psychiatr Scand. 2013;127(5):403–411. doi:10.1111/acps.1200322924855
  • Michalak EE, Yatham LN, Kolesar S, Lam RW. Bipolar disorder and quality of life: a patient-centered perspective. Qual Life Res. 2006;15(1):25–37. doi:10.1007/s11136-005-0376-716411028

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.